Drug Shortage Report for JAMP OLMESARTAN
| Report ID | 246783 |
| Drug Identification Number | 02461641 |
| Brand name | JAMP OLMESARTAN |
| Common or Proper name | Olmesartan Medoxomil Tablets USP |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | OLMESARTAN MEDOXOMIL |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 3x10 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-12-23 |
| Estimated end date | 2025-01-31 |
| Actual end date | 2025-03-17 |
| Shortage status | Resolved |
| Updated date | 2025-03-18 |
| Company comments | Format 100 available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-03-18 | French | Compare |
| v3 | 2025-03-18 | English | Compare |
| v2 | 2025-01-04 | French | Compare |
| v1 | 2025-01-04 | English | Compare |
Showing 1 to 4 of 4